Xconomy National

Archives

by in

Entry	Author	Date	Location
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter	Gregory T. Huang	10/28/11	Boston
Sabet and Wilson Out at Twitter, Hirshland Out at Polaris, & More VC Comings and Goings	Gregory T. Huang	09/22/11	Boston
Tech Startup Investing, Following the Seasonal Pattern, Falls to $250M in July	Erin Kutz	08/17/11	Boston
VC Investments in Boston Companies Soar to 1999 Levels ($1B+); Here Are the Top 10 Deals from the 2nd Quarter	Gregory T. Huang	07/21/11	Boston
Compuware Scoops Up DynaTrace, Medtronic Buys Salient Surgical, Avedro Snaps Up $25M, & More Boston-Area Deals News	Erin Kutz	07/13/11	Boston
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News	Erin Kutz	07/08/11	Boston
Zafgen Pockets $33M To Take Obesity Drug Through Next Big Step in Clinical Trials	Arlene Weintraub	07/07/11	Boston
Zafgen Lands $33,000,000 Series C Round	VentureDeal	07/07/11	Boston
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News	Erin Kutz	01/07/11	Boston
Zafgen Weight Loss Drug Shows Promise in First Human Test	Luke Timmerman	01/05/11	Boston
Third Rock Ventures Secures $426M Second Fund, Makes Changes to Partner Ranks	Ryan McBride	09/13/10	Boston
Third Rock Ventures, Firm With Hunger for Audacious Biotech Ideas, Sets up SF Shop	Luke Timmerman	08/12/10	San Francisco
Tethys Pockets $33M, Achaogen’s Vision for Antibiotics, Genentech Strikes Out at FDA Panel, & More Bay Area Life Sciences News	Luke Timmerman	07/23/10	San Francisco
Lessons Learned About the Outlook for New Obesity Drug Approval	Tom Hughes	07/16/10	National
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly Deal	Ryan McBride	07/08/10	Boston
Marathon and Zafgen Add to Series B Rounds, Athenahealth and Sermo Announce Partnership, Sensata Sets IPO Terms, & More Boston-Area Deals News	Erin Kutz	03/03/10	Boston
Zafgen Grabs $8.1M More in B Round	Ryan McBride	03/01/10	Boston
Zafgen Lands $8,100,000 Series B Financing	VentureDeal	03/01/10	Boston
Zafgen Plans Weight-Loss Study, Infinity CEO Perkins Plans for Growth, Boston Scientific Cuts 1000+ Jobs, & More Boston-Area Life Sciences News	Rebecca Zacks	02/12/10	Boston
Former CombinatoRx CEO Alexis Borisy Lands at Third Rock Ventures, Launches New Startup	Ryan McBride	02/11/10	Boston
Zafgen’s Mysterious Weight Loss Drug Advances Into First Trial for Obese Women	Luke Timmerman	02/08/10	Boston
The Transformative Twelve: Presenting the XSITE Xpo Showcase	Editors	06/19/09	Boston
How to Raise $50M in a Recession: Highlights from the Xconomy Life Sciences Forum	Luke Timmerman	05/01/09	Boston
Let’s Talk About Tomorrow, People—at Next Week’s Xconomy Biotech Forum	Rebecca Zacks	04/24/09	Boston
Harvard Researcher to Helm Merck’s Cancer Research, Genzyme Acquires Certain Exact Sciences Assets, NeurAxon Out to Axe Migraines, & More Boston-Area Life Sciences	Rebecca Zacks	02/04/09	Boston
Exact Teams With Genzyme, Shrugs off Sequenom; Virtual Computer Reels in $15M; Beacon Power Inks National Grid Agreement; & More Boston-Area Deal News	Rebecca Zacks	01/30/09	Boston
Atlas Venture Closes New Fund with $283M, Does the Staffing Shuffle	Rebecca Zacks	01/29/09	Boston
Zafgen Cuts Deal With Argenta	Luke Timmerman	01/29/09	Boston
Zafgen’s Big Idea: Fight Fat by Cutting Off Its Blood Supply	Luke Timmerman	01/28/09	Boston
RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News	Rebecca Zacks	11/20/08	Boston
Page 1 of 2	next page »